Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
McKesson
Citi
Julphar
Boehringer Ingelheim
Mallinckrodt
Chinese Patent Office
Farmers Insurance
AstraZeneca
Queensland Health

Generated: August 18, 2017

DrugPatentWatch Database Preview

Strontium chloride sr-89 - Generic Drug Details

« Back to Dashboard

What are the generic sources for strontium chloride sr-89 and what is the scope of strontium chloride sr-89 freedom to operate?

Strontium chloride sr-89
is the generic ingredient in two branded drugs marketed by Ge Healthcare and Bio Nucleonics, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for strontium chloride sr-89. Two suppliers are listed for this compound.

Summary for Generic Name: strontium chloride sr-89

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list16
Suppliers / Packagers: see list2
Clinical Trials: see list468
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:strontium chloride sr-89 at DailyMed

Pharmacology for Ingredient: strontium chloride sr-89

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bio Nucleonics
STRONTIUM CHLORIDE SR-89
strontium chloride sr-89
INJECTABLE;INJECTION075941-001Jan 6, 2003APRXNoNo► Subscribe► Subscribe► Subscribe
Ge Healthcare
METASTRON
strontium chloride sr-89
INJECTABLE;INJECTION020134-001Jun 18, 1993APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Accenture
Fuji
Fish and Richardson
Covington
Federal Trade Commission
Mallinckrodt
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot